Skip to main content
Top
Published in:

Open Access 21-02-2025 | Acute Pancreatitis | Case report

Isotretinoin-induced pancreatitis: is it time to definitely recognize it: a case report

Authors: Julien Barras, Maxime Poncin, Pierrette Gast, Édouard louis, Jean-Philippe Loly

Published in: Journal of Medical Case Reports | Issue 1/2025

Login to get access

Abstract

Background

Although often overlooked, drug-induced pancreatitis is a frequent cause of pancreatitis. Pancreatic drug toxicity is defined according to the classification by Mallory et al. and Trivedi et al. Isotretinoin is only classified as possibly toxic to the pancreas (class 3). We report the first case of recurrence of pancreatitis after rechallenge, which argues for a modification of the classification of drug-induced pancreatitis.

Case presentation

We present here the case of a 20-year-old Belgian man who suffered several episodes of acute pancreatitis for which no etiology could be identified despite an exhaustive assessment. Eventually, as a precaution, isotretinoin was discontinued and there was no recurrence until it was reintroduced.

Conclusion

This is the 25th case described in the literature, but the first with a positive rechallenge on two occasions. This case therefore implies that isotretinoin should definitely be considered a class 1 toxic drug for the pancreas and should be incriminated in acute pancreatitis in patients treated with this drug.
Literature
1.
go back to reference Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet Lond Engl. 2015;386(9988):85–96.CrossRef Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet Lond Engl. 2015;386(9988):85–96.CrossRef
3.
go back to reference Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006;33(4):323–30.CrossRefPubMed Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006;33(4):323–30.CrossRefPubMed
4.
go back to reference Spanier BWM, Tuynman HARE, van der Hulst RWM, Dijkgraaf MGW, Bruno MJ. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol déc. 2011;106(12):2183–8.CrossRef Spanier BWM, Tuynman HARE, van der Hulst RWM, Dijkgraaf MGW, Bruno MJ. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol déc. 2011;106(12):2183–8.CrossRef
5.
go back to reference Jones E, Korzenko A, Kriegel D. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma. J Drugs Dermatol JDD. 2004;3(5):498–502.PubMed Jones E, Korzenko A, Kriegel D. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma. J Drugs Dermatol JDD. 2004;3(5):498–502.PubMed
6.
go back to reference Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Isotretinoin a review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs. 1984;28(1):6–37.CrossRefPubMed Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Isotretinoin a review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs. 1984;28(1):6–37.CrossRefPubMed
7.
go back to reference Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg sept. 2008;27(3):197–206.CrossRef Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg sept. 2008;27(3):197–206.CrossRef
8.
go back to reference Mallory A, Kern F. Drug-induced pancreatitis: a critical review. Gastroenterology avr. 1980;78(4):813–20.CrossRef Mallory A, Kern F. Drug-induced pancreatitis: a critical review. Gastroenterology avr. 1980;78(4):813–20.CrossRef
9.
go back to reference Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol sept. 2005;39(8):709–16.CrossRef Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol sept. 2005;39(8):709–16.CrossRef
10.
go back to reference Flynn WJ, Freeman PG, Wickboldt LG. Pancreatitis associated with isotretinoin-induced hypertriglyceridemia. Ann Intern Med juill. 1987;107(1):63.CrossRef Flynn WJ, Freeman PG, Wickboldt LG. Pancreatitis associated with isotretinoin-induced hypertriglyceridemia. Ann Intern Med juill. 1987;107(1):63.CrossRef
11.
go back to reference McCarter TL, Chen YK. Marked hyperlipidemia and pancreatitis associated with isotretinoin therapy. Am J Gastroenterol déc. 1992;87(12):1855–8. McCarter TL, Chen YK. Marked hyperlipidemia and pancreatitis associated with isotretinoin therapy. Am J Gastroenterol déc. 1992;87(12):1855–8.
12.
go back to reference Aurousseau MH, Levacher S, Bénéton C, Blaise M, Pourriat JL. Transient dysfibrinogenemia and thrombocytopenia associated with recurrent acute pancreatitis in the course of isotretinoin therapy. Rev Med Interne. 1995;16(8):622–5.CrossRefPubMed Aurousseau MH, Levacher S, Bénéton C, Blaise M, Pourriat JL. Transient dysfibrinogenemia and thrombocytopenia associated with recurrent acute pancreatitis in the course of isotretinoin therapy. Rev Med Interne. 1995;16(8):622–5.CrossRefPubMed
13.
go back to reference Bourantas KL, Tsiara S, Christou L. Treatment of 34 patients with myelodysplastic syndromes with 13-CIS retinoic acid. Eur J Haematol. 1995;55(4):235–9.CrossRefPubMed Bourantas KL, Tsiara S, Christou L. Treatment of 34 patients with myelodysplastic syndromes with 13-CIS retinoic acid. Eur J Haematol. 1995;55(4):235–9.CrossRefPubMed
14.
go back to reference Jamshidi M, Obermeyer RJ, Govindaraj S, Garcia A, Ghani A. Acute pancreatitis secondary to isotretinoin-induced hyperlipidemia. J Okla State Med Assoc févr. 2002;95(2):79–80. Jamshidi M, Obermeyer RJ, Govindaraj S, Garcia A, Ghani A. Acute pancreatitis secondary to isotretinoin-induced hyperlipidemia. J Okla State Med Assoc févr. 2002;95(2):79–80.
15.
go back to reference Fine JD, Johnson LB, Weiner M, Stein A, Suchindran C. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin. J Am Acad Dermatol avr. 2004;50(4):563–71.CrossRef Fine JD, Johnson LB, Weiner M, Stein A, Suchindran C. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin. J Am Acad Dermatol avr. 2004;50(4):563–71.CrossRef
17.
go back to reference See SJ, Levin VA, Yung WKA, Hess KR, Groves MD. 13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme. Neuro-Oncol juill. 2004;6(3):253–8.CrossRef See SJ, Levin VA, Yung WKA, Hess KR, Groves MD. 13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme. Neuro-Oncol juill. 2004;6(3):253–8.CrossRef
18.
go back to reference Greene JP. An adolescent with abdominal pain taking isotretinoin for severe acne. South Med J sept. 2006;99(9):992–4.CrossRef Greene JP. An adolescent with abdominal pain taking isotretinoin for severe acne. South Med J sept. 2006;99(9):992–4.CrossRef
19.
go back to reference Pillai RN, Aisner J, Dahlberg SE, Rogers JS, DiPaola RS, Aisner S, et al. Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501). Cancer Chemother Pharmacol juill. 2014;74(1):177–83.CrossRef Pillai RN, Aisner J, Dahlberg SE, Rogers JS, DiPaola RS, Aisner S, et al. Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501). Cancer Chemother Pharmacol juill. 2014;74(1):177–83.CrossRef
20.
go back to reference Acute pancreatitis linked to isotretinoin. 2015 Prescrire Int. Févr 24(157):46. Acute pancreatitis linked to isotretinoin. 2015 Prescrire Int. Févr 24(157):46.
21.
go back to reference Tejedor Tejada J, Torres Yuste R, García PF. Acute pancreatitis secondary to treatment with isotretinoin. Gastroenterol Hepatol avr. 2019;42(4):256.CrossRef Tejedor Tejada J, Torres Yuste R, García PF. Acute pancreatitis secondary to treatment with isotretinoin. Gastroenterol Hepatol avr. 2019;42(4):256.CrossRef
22.
go back to reference Atiq MU, Raza A, Ashfaq A. Idiosyncratic reaction causing a rare side effect: isotretenoin-induced pancreatitis. Cureus. 2019;11(11): e6102.PubMedPubMedCentral Atiq MU, Raza A, Ashfaq A. Idiosyncratic reaction causing a rare side effect: isotretenoin-induced pancreatitis. Cureus. 2019;11(11): e6102.PubMedPubMedCentral
Metadata
Title
Isotretinoin-induced pancreatitis: is it time to definitely recognize it: a case report
Authors
Julien Barras
Maxime Poncin
Pierrette Gast
Édouard louis
Jean-Philippe Loly
Publication date
21-02-2025
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2025
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-025-05097-2